Literature DB >> 29268386

The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection.

Youngkyu Moon1, Kyo Young Lee2, Jae Kil Park1.   

Abstract

BACKGROUND: Ground-glass opacity (GGO) on chest computed tomography (CT) is generally associated with non-invasive or minimally invasive adenocarcinoma (MIA). However, many instances of GGO are diagnosed as invasive adenocarcinoma. The purpose of this study is to analyse the histopathologic characteristics of invasive adenocarcinoma presenting as GGO and the prognosis after sublobar resection.
METHODS: We conducted a retrospective chart review of 191 patients who were treated for stage I non-small cell lung cancer presenting as a GGO-predominant tumour upon CT and who underwent curative resection. We analysed the histologic subtypes and components of invasive adenocarcinomas presenting as GGO-predominant tumours. We also compared the 5-year recurrence-free survival (RFS) of invasive adenocarcinomas presenting as GGO-predominant in patients undergoing sublobar resection or lobectomy.
RESULTS: Of 191 GGO-predominant tumour patients, 97 patients had adenocarcinoma in situ (AIS) or MIA, and 94 patients had invasive adenocarcinoma. In the analysis of the histologic component of invasive adenocarcinoma presenting as GGO, the mean rate of the lepidic component was 47.4%, that of the acinar component was 42.1%, and that of the papillary component was 7.3%. Micropapillary and solid components were nearly absent. The 5-year RFS rates of sublobar resection and lobectomy were both 100%.
CONCLUSIONS: Invasive components such as acinar and papillary components can also be seen as GGO tumours on chest CT. After the sublobar resection of GGO-predominant tumours, a good prognosis can be expected, even if the tumour is an invasive adenocarcinoma such as the acinar or papillary subtypes.

Entities:  

Keywords:  Ground glass opacity; invasive adenocarcinoma; sublobar resection

Year:  2017        PMID: 29268386      PMCID: PMC5723887          DOI: 10.21037/jtd.2017.09.40

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  26 in total

1.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

Review 2.  What is the most practical, optimal, and cost effective method for performing follow-up after lung cancer surgery, and by whom should it be done?

Authors:  Lise Tremblay; Jean Deslauriers
Journal:  Thorac Surg Clin       Date:  2013-06-28       Impact factor: 1.750

3.  Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.

Authors:  Shinsuke Sasada; Haruhiko Nakayama; Yoshihiro Miyata; Norifumi Tsubokawa; Takahiro Mimae; Tomoharu Yoshiya; Shuji Murakami; Hiroyuki Ito; Morihito Okada
Journal:  Ann Thorac Surg       Date:  2015-01-23       Impact factor: 4.330

4.  Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma.

Authors:  Youngkyu Moon; Sook Whan Sung; Kyo Young Lee; Sung Bo Sim; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

5.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Authors:  Takashi Eguchi; Kyuichi Kadota; Bernard J Park; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16

6.  Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma.

Authors:  Tomoharu Yoshiya; Takahiro Mimae; Yasuhiro Tsutani; Norifumi Tsubokawa; Shinsuke Sasada; Yoshihiro Miyata; Kei Kushitani; Yukio Takeshima; Shuji Murakami; Hiroyuki Ito; Haruhiko Nakayama; Morihito Okada
Journal:  Ann Thorac Surg       Date:  2016-06-23       Impact factor: 4.330

7.  Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons.

Authors:  Ha Young Kim; Young Mog Shim; Kyung Soo Lee; Joungho Han; Chin A Yi; Yoon Kyung Kim
Journal:  Radiology       Date:  2007-10       Impact factor: 11.105

8.  Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography: Comparison with Solitary Invasive Adenocarcinoma.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  J Thorac Oncol       Date:  2016-01-21       Impact factor: 15.609

9.  Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications.

Authors:  Hyun-Ju Lim; Soomin Ahn; Kyung Soo Lee; Joungho Han; Young Mog Shim; Sookyoung Woo; Jae-Hun Kim; Miyeon Yie; Ho Yun Lee; Chin A Yi
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

10.  Correlation of histological components with tumor invasion in pulmonary adenocarcinoma.

Authors:  Youngkyu Moon; Kyung Soo Kim; Sook Whan Sung; Kyo-Young Lee; Young Kyoon Kim; Jin Hyoung Kang; Yeon Sil Kim; Jae Kil Park
Journal:  World J Surg Oncol       Date:  2014-12-17       Impact factor: 2.754

View more
  19 in total

1.  Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study.

Authors:  Pranjal Vaidya; Kaustav Bera; Philip A Linden; Amit Gupta; Prabhakar Shantha Rajiah; David R Jones; Matthew Bott; Harvey Pass; Robert Gilkeson; Frank Jacono; Kevin Li-Chun Hsieh; Gong-Yau Lan; Vamsidhar Velcheti; Anant Madabhushi
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

2.  Clinical characteristics and prognosis of ground-glass opacity nodules in young patients.

Authors:  Jun Wang; Han Ma; Chong-Jun Ni; Jing-Kang He; Hai-Tao Ma; Jin-Feng Ge
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

3.  Selecting therapy for small ground-glass tumors-the potential role of volumetric computed tomography scan.

Authors:  Xiangwen Wu; Hiran C Fernando
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

4.  Novel Asymmetrical Linear Stapler (NALS) for pathologic evaluation of true resection margin tissue.

Authors:  Shin-Kwang Kang; Jin San Bok; Hyun Jin Cho; Min-Woong Kang
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

5.  GGO and minimally invasive adenocarcinomas: how to deal with?

Authors:  Nicolas Girard
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

6.  Predictive factors for invasive adenocarcinoma in patients with clinical non-invasive or minimally invasive lung cancer.

Authors:  Youngkyu Moon; Jae Kil Park; Kyo Young Lee; Seha Ahn; Jinwon Shin
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

7.  Optimal margins for early stage peripheral lung adenocarcinoma resection.

Authors:  Pan Yin; Bingqing Yue; Ji Zhang; Dong Liu; Dongyu Bai; Guang Zhao; Chutong Huang; Guojun Geng; Jie Jiang; Yongxiang Su; Xiuyi Yu; Jingyu Chen
Journal:  BMC Cancer       Date:  2021-05-11       Impact factor: 4.430

8.  Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma.

Authors:  Qi Li; Xiao-Qun He; Xiao Fan; Chao-Nan Zhu; Jun-Wei Lv; Tian-You Luo
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

9.  Should resection extent be decided by total lesion size or solid component size in ground glass opacity-containing lung adenocarcinomas?

Authors:  Boyu Lin; Rui Wang; Liang Chen; Zhitao Gu; Chunyu Ji; Wentao Fang
Journal:  Transl Lung Cancer Res       Date:  2021-06

10.  3D convolutional neural network for differentiating pre-invasive lesions from invasive adenocarcinomas appearing as ground-glass nodules with diameters ≤3 cm using HRCT.

Authors:  Shengping Wang; Rui Wang; Shengjian Zhang; Ruimin Li; Yi Fu; Xiangjie Sun; Yuan Li; Xing Sun; Xinyang Jiang; Xiaowei Guo; Xuan Zhou; Jia Chang; Weijun Peng
Journal:  Quant Imaging Med Surg       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.